Long-term survival after kidney transplantation

S Hariharan, AK Israni… - New England Journal of …, 2021 - Mass Medical Soc
Long-Term Survival after Kidney Transplantation This review discusses demographics,
survival, and risks in kidney transplantation since the mid-1990s. It addresses postoperative …

CD28 costimulation: from mechanism to therapy

JH Esensten, YA Helou, G Chopra, A Weiss… - Immunity, 2016 - cell.com
Ligation of the CD28 receptor on T cells provides a critical second signal alongside T cell
receptor (TCR) ligation for naive T cell activation. Here, we discuss the expression, structure …

Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations

D Schubert, C Bode, R Kenefeck, TZ Hou, JB Wing… - Nature medicine, 2014 - nature.com
The protein cytotoxic T lymphocyte antigen-4 (CTLA-4) is an essential negative regulator of
immune responses, and its loss causes fatal autoimmunity in mice. We studied a large family …

HLA-G: an immune checkpoint molecule

ED Carosella, N Rouas-Freiss, D Tronik-Le Roux… - Advances in …, 2015 - Elsevier
HLA-G is a molecule that was first known to confer protection to the fetus from destruction by
the immune system of its mother, thus critically contributing to fetal–maternal tolerance. The …

Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs

H Parlakpinar, M Gunata - Immunopharmacology and …, 2021 - Taylor & Francis
Immunosuppressive drugs used in the transplantation period are generally defined as
induction and maintenance therapy. The use of immunosuppressants, which are particularly …

Interleukin-6, a cytokine critical to mediation of inflammation, autoimmunity and allograft rejection: therapeutic implications of IL-6 receptor blockade

SC Jordan, J Choi, I Kim, G Wu, M Toyoda, B Shin… - …, 2017 - journals.lww.com
The success of kidney transplants is limited by the lack of robust improvements in long-term
survival. It is now recognized that alloimmune responses are responsible for the majority of …

Calcineurin inhibitor nephrotoxicity

M Naesens, DRJ Kuypers, M Sarwal - Clinical Journal of the …, 2009 - journals.lww.com
The use of the calcineurin inhibitors cyclosporine and tacrolimus led to major advances in
the field of transplantation, with excellent short-term outcome. However, the chronic …

[HTML][HTML] A phase III study of belatacept‐based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)

F Vincenti, B Charpentier, Y Vanrenterghem… - American Journal of …, 2010 - Elsevier
Belatacept, a costimulation blocker, may preserve renal function and improve long‐term
outcomes versus calcineurin inhibitors in kidney transplantation. This Phase III study …

Rejection of the kidney allograft

BJ Nankivell, SI Alexander - New England Journal of Medicine, 2010 - Mass Medical Soc
Rejection of the Kidney Allograft | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

T Orban, B Bundy, DJ Becker, LA DiMeglio… - The Lancet, 2011 - thelancet.com
Background The immunopathogenesis of type 1 diabetes mellitus is associated with T-cell
autoimmunity. To be fully active, immune T cells need a co-stimulatory signal in addition to …